Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Shanghai · hospital | China | none recorded | 0 | 3,733 | 40,855 | - | |
Rotterdam · cancer center | Netherlands | none recorded | 0 | 883 | 11,289 | - | |
Cambridge · hospital | United Kingdom | none recorded | 0 | 791 | 10,494 | - | |
Munich · university | Germany | none recorded | 0 | 535 | 4,636 | - | |
| Switzerland | none recorded | 0 | 407 | 4,182 | - | ||
Rome · cancer center | Italy | none recorded | 0 | 381 | 2,833 | - | |
São Paulo · cancer center | Brazil | none recorded | 0 | 358 | 2,128 | - | |
Chandigarh · hospital | India | none recorded | 0 | 327 | 2,426 | - | |
London · hospital | United Kingdom | none recorded | 0 | 318 | 3,038 | - | |
Madrid · research institute | Spain | none recorded | 0 | 294 | 4,125 | - | |
Cambridge, MA · research institute | United States | 0 | 181 | 5,875 | - | ||
Uppsala · hospital | Sweden | none recorded | 0 | 177 | 1,457 | - | |
Rehovot · research institute | Israel | none recorded | 0 | 171 | 4,815 | - | |
Belfast · hospital | United Kingdom | none recorded | 0 | 158 | 585 | - | |
Glasgow · hospital | United Kingdom | none recorded | 0 | 155 | 1,994 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Grade 3 well-differentiated neuroendocrine tumour but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.